tiprankstipranks
Quince Therapeutics (QNCX)
NASDAQ:QNCX
US Market
Holding QNCX?
Track your performance easily

Quince Therapeutics (QNCX) Financial Statements

530 Followers

Quince Therapeutics Financial Overview

Quince Therapeutics's market cap is currently ―. The company's EPS TTM is $-1.247; its P/E ratio is -1.63; Quince Therapeutics is scheduled to report earnings on March 4, 2025, and the estimated EPS forecast is $-0.18. See an overview of income statement, balance sheet, and cash flow financials.
Sep 24Jun 24Mar 24Jun 23Mar 23
Income Statement-
Total Revenue-----
Gross Profit-----
EBIT$ -5.48M$ -27.69M$ -8.19M$ -4.89M$ -12.50M
EBITDA$ -5.39M$ -27.65M$ -8.14M$ -4.88M$ -12.48M
Net Income Common Stockholders$ -5.49M$ -27.73M$ -11.15M$ -4.89M$ -12.25M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 45.17M$ 51.55M$ 46.01M$ 64.92M$ 43.49M
Total Assets$ 126.52M$ 134.83M$ 159.29M$ 88.84M$ 93.32M
Total Debt$ 15.35M$ 14.29M$ 14.00M$ 0.00$ 0.00
Net Debt$ -29.82M$ -37.27M$ -32.01M$ -64.92M$ -43.49M
Total Liabilities$ 81.59M$ 87.86M$ 85.11M$ 1.95M$ 3.12M
Stockholders Equity$ 44.93M$ 46.97M$ 74.18M$ 86.88M$ 90.20M
Cash Flow-
Free Cash Flow$ -7.31M$ -8.78M$ -8.39M$ -3.74M$ -3.71M
Operating Cash Flow$ -7.26M$ -8.74M$ -8.35M$ -3.83M$ -3.57M
Investing Cash Flow$ 7.11M$ -4.98M$ 8.91M$ -20.32M$ 5.54M
Financing Cash Flow$ -5.00M$ 35.00K$ 190.00K$ 26.00K$ 50.00K
Currency in USD

Quince Therapeutics Earnings and Revenue History

Quince Therapeutics Debt to Assets

Quince Therapeutics Cash Flow

Quince Therapeutics Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis